Oncology Fellowship

Gynecologic Oncology Fellow Research

Javellana M, Eckert MA, Heide J, Zawieracz K, Weigert M, Ashley S, Stock E, Chapel D, Huang L, Yamada SD, Ahmed AA, Lastra RR, Chen M, Lengyel E. Neoadjuvant chemotherapy induces genomic and transcriptomic changes in ovarian cancer. Cancer Res. 2021 Nov 4:canres.1467.2021. doi: 10.1158/0008-5472.CAN-21-1467. Online ahead of print. PMID: 34737212

Eckert MA, Orozco C, Xiao J, Javellana M, Lengyel E. The Effects of Chemotherapeutics on the Ovarian Cancer Microenvironment. Cancers (Basel). 2021 Jun 23;13(13):3136. doi: 10.3390/cancers13133136. PMID: 34201616

Ackroyd SA, Lee NK. "The promise and vulnerability of telemedicine". Gynecol Oncol. 2021 Jul;162(1):1-3. doi: 10.1016/j.ygyno.2021.06.004. PMID: 34154727 

Ackroyd SA, Shih YT, Kim B, Lee NK, Halpern MT. A look at the gynecologic oncologist workforce - Are we meeting patient demand? Gynecol Oncol. 2021 Nov;163(2):229-236. doi: 10.1016/j.ygyno.2021.08.013. Epub 2021 Aug 27. PMID: 34456058

Ackroyd SA, Huang ES, Kurnit KC, Lee NK. Pembrolizumab and lenvatinib versus carboplatin and paclitaxel as first-line therapy for advanced or recurrent endometrial cancer: A Markov analysis. Gynecol Oncol. 2021 Aug;162(2):249-255. doi: 10.1016/j.ygyno. 2021.05.038. Epub 2021 Jun 6. PMID: 34103196 

Ackroyd SA, Hernandez E, Houck K. Reply to "Rebuttal for: Postoperative complications of epidural analgesia at hysterectomy for gynecologic malignancies: an analysis of the National Surgical Quality Improvement Program". Int J Gynecol Cancer. 2020 Dec;30(12):2021. doi: 10.1136/ijgc-2020-002126. Epub 2020 Nov 22. PMID: 33223500

 

Former Fellows

Fellow

Thesis

Thesis Mentor

Current Institution

Raanan Alter, MD

2018-2021

Strategies to reverse immunosuppression in PTEN deficient gynecologic cancers by tumor cell intrinsic STING/IFN-B signaling

Akash Patnaik, MD

Northwestern Medicine

Isabel Lazo, MD

2017-2020

Profiling metabolite changes in the ovarian cancer secretome and its impact on alterations in human primary mesothelial cells

Ernst Lengyel, MD, PhD

Hilary Kenny, PhD

Stanford Medicine

Claire Hoppenot, MD, PhD

2016-2019

Genomics and proteomics of long-term survivors of advanced-stage high-grade serous ovarian cancer

Ernst Lengyel, MD

Baylor College of Medicine

Jerlinda Ross, MD, MS

2015-2018

Endometrial Cancer Survivor’s Access to Recommended Self-Care Resources for Obesity in a High-Poverty Urban Community

Stacy Lindau, MD, MAPP
Diane Yamada, MD

Nita Lee, MD, MPH

Medical University of South Carolina

Josephine Kim, MD

2014-2017

Combination simvastatin/metformin for endometrial cancer treatment and prevention

Gustavo Rodriguez, MD

University of Chicago

Terri Febbraro, MD

2013-2016

Inhibition of BI integrin impedes ovarian cancer metastasis via redirection in lactate production resulting in decreased proliferation, angiogenesis and cancer stem cell population

Ernst Lengyel, MD, PhD

MaineHealth Medical Center

Andrea Jewel, MD

2012-2015

MicroRNA 206 is associated with longer overall survival and platinum sensitivity in serous epithelial ovarian cancer

Ernst Lengyel, MD, PhD

The University of Kansas Health System

Andras Ladyani, MD

2011-2014

Expression of fatty acid transporters in ovarian cancer

Ernst Lengyel, MD, PhD

Rush University Medical Center

Jessica Hunn, MD

2011-2014

Developing an effective pharmacologic approach for the chemoprevention of ovarian and uterine cancer

Gustavo Rodriguez, MD

Valley Women’s Health